Associated with longer life expectancy, greater survival of patients with cardiovascular disorders, and increased use of wearable and insertable/implantable devices capable of detection, the frequency of atrial fibrillation (AF) diagnosis is increasing. This chapter describes two representative patient cases that were used to enable a discussion of the evaluation and management of AF in different scenarios. One patient is young and healthy with paroxysmal AF but no major comorbidities (though there is a family history of AF). The other is older with multiple complicating comorbidities. These cases sparked an active discussion among the panelists that demonstrated not only the multitude of considerations when choosing the optimal therapy for each individual, but also the individualistic differences in biases and styles that can exist between experts in the field. The results of these discussions revealed agreement that.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2023.08.018DOI Listing

Publication Analysis

Top Keywords

chapter aad
4
patient
4
aad patient
4
patient populations
4
populations patient-centric
4
patient-centric approach
4
approach optimal
4
optimal patient
4
patient management
4
management associated
4

Similar Publications

Article Synopsis
  • The American Academy of Dermatology (AAD) published guidelines in 2014 for diagnosing and managing atopic dermatitis, developed by a team of twelve clinicians.
  • The guidelines emphasize the use of clinical evidence for diagnosis and recommend nonpharmacologic therapies first to restore the skin barrier, followed by topical and systemic treatments for moderate-to-severe cases.
  • An updated set of guidelines was created to educate physicians on new treatment options and emerging evidence for better management of atopic dermatitis.
View Article and Find Full Text PDF

Atopic Dermatitis Disease Education.

Adv Exp Med Biol

May 2024

Department of Dermatology, The Mount Sinai Hospital, New York, NY, USA.

There has been an influx of new educational resources for atopic dermatitis (AD) patients in recent years. The two primary organizations in the United States offering educational materials, online resources, and other forms of support include the National Eczema Association (NEA) and the American Academy of Dermatology (AAD). Educational workshops and interventions have emerged as tools that can deliver comprehensive information on AD, such as symptoms, treatments, and disease management.

View Article and Find Full Text PDF

Chapter 2: Rate Versus Rhythm Control.

Am J Cardiol

October 2023

TCA (Texas Cardiac Arrhythmia) Heart, Dallas, TX, USA.

Atrial fibrillation (AF) is a potentially serious health risk, both because of its symptoms and because of its association with an increased risk for heart failure, hospitalization, thromboembolism, and death. Chapter 2 discusses selection of appropriate treatments and when to initiate these therapies. Older trials focused on comparing rate versus rhythm control treatment options for AF.

View Article and Find Full Text PDF

Associated with longer life expectancy, greater survival of patients with cardiovascular disorders, and increased use of wearable and insertable/implantable devices capable of detection, the frequency of atrial fibrillation (AF) diagnosis is increasing. This chapter describes two representative patient cases that were used to enable a discussion of the evaluation and management of AF in different scenarios. One patient is young and healthy with paroxysmal AF but no major comorbidities (though there is a family history of AF).

View Article and Find Full Text PDF

Chapter 5: Guideline Recommendations: Which AAD and for Whom?

Am J Cardiol

October 2023

TCA (Texas Cardiac Arrhythmia) Heart, Dallas, TX, USA.

This chapter discusses the American College of Cardiology/American Heart Association/ Heart Rhythm Society (AHA/ACC/HRS) and European Society of Cardiology (ESC) guidelines for atrial fibrillation (AF) management with particular focus on antiarrhythmic drug (AAD) selection and the identification of individuals for whom AAD treatment is appropriate. Discussion includes AAD indications, when to start an AAD, choosing among AADs, how to minimize proarrhythmic risk, how to determine efficacy, and the use of adjuvant interventions. The indications for all AADs are based on safety; the current AHA/ACC/HRS and ESC guidelines state that the choice of AAD is based on the presence or absence of structural heart disease (SHD), coronary artery disease, or heart failure (HF), with further recommendations in the ESC guidelines based on HF type (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!